Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 41Melanoma 8Uterine Cervical Neoplasms 7Endometrial Neoplasms 7Mouth Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 4Vulvar Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Uterine Neoplasms 2Rectal Neoplasms 2Neoplasm Micrometastasis 2Neoplasm Metastasis 2Lymphatic Metastasis 2Leukemia, Lymphocytic, Chronic, B-Cell 2Head and Neck Neoplasms 2Eccrine Porocarcinoma 2Breast Neoplasms, Male 2Breast Carcinoma In Situ 2Waldenstrom Macroglobulinemia 1Sentinel Lymph Node Biopsy (SLNB) 1Sentinel Lymph Node 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Recurrence 1Recurent Vulvar Carcinoma 1Prostatic Neoplasms 1Penile Neoplasms 1Pediatric Patients With Solid Tumors 1Pancreatic Neoplasms 1

Interventions

Carboplatin 177Radiotherapy 139Cisplatin 110Pemetrexed 102Docetaxel 93Paclitaxel 92Gemcitabine 78Erlotinib Hydrochloride 73Magnetic Resonance Spectroscopy 72Radiosurgery 67Bevacizumab 65pembrolizumab 64Etoposide 60Blood Specimen Collection 60durvalumab 53Specimen Handling 48Nivolumab 48Surveys and Questionnaires 47Drug Therapy 41Standard of Care 35Radiation 33osimertinib 32atezolizumab 32Surgical Procedures, Operative 30Topotecan 29Irinotecan 29Gefitinib 29Educational Status 29Early Intervention, Educational 29Biopsy 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Neoplasms × Sentinel Lymph Node Biopsy × Clear all
NCT00264602 2025-11-10

Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

Massachusetts General Hospital

Phase 1 Active not recruiting
57 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡